Primary Leptomeningeal Gliomatosis in Children and Adults: A Morphological and Molecular Comparative Study With Literature Review

Neurosurgery. 2016 Mar;78(3):343-52. doi: 10.1227/NEU.0000000000001028.

Abstract

Background: Primary leptomeningeal gliomatosis (PLG) is a poorly recognized tumor of the central nervous system.

Objective: To describe the histopathological, immunohistochemical, and molecular features of PLG.

Methods: Results of our multicentric retrospective study of 6 PLG cases (3 pediatric and 3 adult) were compared with literature data.

Results: The mean age was 54.7 years for adults and 8.7 years for children, with 3 males and 3 females. Clinical symptoms were nonspecific. Cerebrospinal fluid analyses showed a high protein level often associated with pleocytosis but without neoplastic cells. On neuroimaging, diffuse leptomeningeal enhancement and hydrocephalus were observed, except in 1 case. PLG was mostly misinterpreted as infectious or tumoral meningitis. The first biopsy was negative in 50% of cases. Histopathologically, PLG cases corresponded to 1 oligodendroglioma without 1p19q codeletion and 5 astrocytomas without expression of p53. No immunostaining for IDH1R132H and no mutations of IDH1/2 and H3F3A genes were found. Overall survival was highly variable (2-82 months) but seems to be increased in children treated with chemotherapy.

Conclusion: This study shows the difficulties of PLG diagnosis. The challenge is to achieve an early biopsy to establish a diagnosis and to begin a treatment, but the prognosis remains poor. PLG seems to have a different molecular and immunohistochemical pattern compared with intraparenchymal malignant gliomas.

Publication types

  • Comparative Study
  • Multicenter Study

MeSH terms

  • Adult
  • Biomarkers, Tumor / analysis
  • Child
  • Child, Preschool
  • Female
  • Humans
  • Male
  • Meningeal Carcinomatosis / diagnosis*
  • Meningeal Carcinomatosis / mortality
  • Neoplasms, Neuroepithelial / diagnosis*
  • Neoplasms, Neuroepithelial / mortality
  • Neuroimaging
  • Prognosis
  • Retrospective Studies

Substances

  • Biomarkers, Tumor